PURE Bioscience, Inc.
PURE · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$464 | -$2,396,933 | -$580 | -$798 |
| Dep. & Amort. | $1 | $1,998 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $146,883 | $33 | $27 |
| Change in WC | $179 | -$154 | $34 | $226 |
| Other Non-Cash | $0 | $2,247,750 | $0 | $0 |
| Operating Cash Flow | -$250 | -$456 | -$512 | -$544 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $350 | $250 | $850 | $400 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $350 | $250 | $850 | $400 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $100 | -$206 | $338 | -$144 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $409 | $615 | $277 | $421 |
| End Cash | $509 | $409,000 | $615 | $277 |
| Free Cash Flow | -$250 | -$456 | -$512 | -$544 |